Medication Safety of Elderly Patients in Hospital and Ambulatory Setting
NCT ID: NCT01578525
Last Updated: 2015-10-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
61 participants
INTERVENTIONAL
2012-04-30
2014-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
standard care
Standard care (by German definition), traditional care by physician and nurse on the ward
No interventions assigned to this group
Intensified standard care
Intensified standard care: traditional care by physician and nurse, additional pharmaceutical care by a pharmacist during hospitalization
Pharmaceutical Care Service
Checking medication under safety considerations (medication at admission, hospitalization, discharge); recommendations for potentially inappropriate medication (PRISCUS-criteria),
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pharmaceutical Care Service
Checking medication under safety considerations (medication at admission, hospitalization, discharge); recommendations for potentially inappropriate medication (PRISCUS-criteria),
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patient admitted to one of the project wards
* minimum hospitalization: 3 days
* written informed consent (patient or the legal representative)
* current medication of the patient at hospitalization
Exclusion Criteria
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Apothekerstiftung Nordrhein, Duesseldorf
UNKNOWN
Foerderinitiative Pharmazeutische Betreuung e.V., Berlin
UNKNOWN
RWTH Aachen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Albrecht Eisert, Dr. rer. nat.
Role: STUDY_DIRECTOR
University Hospital Aachen, Hospital Pharmacy, Steinbergweg 20, 52074 Aachen, Germany
Axel Heidenreich, Prof. Dr. med.
Role: PRINCIPAL_INVESTIGATOR
University Hospital Aachen, Department of Urology, Pauwelsstr. 30, 50274 Aachen, Germany
Joerg B Schulz, Prof. Dr. med.
Role: PRINCIPAL_INVESTIGATOR
University Hospital Aachen, Department of Neurology, Pauwelsstr. 30, 52074 Aachen, Germany
Christian Trautwein, Prof. Dr. med.
Role: PRINCIPAL_INVESTIGATOR
University Hospital Aachen, Internal Medicine III (Gastroenterology and Metabolic Disorders), Pauwelsstr. 30, 52074 Aachen, Germany
Ulrich Jaehde, Prof. Dr. rer. nat.
Role: STUDY_CHAIR
University of Bonn, Pharmaceutical Institute, Clinical Pharmacy, An der Immenburg 4, 53121 Bonn, Germany
Rebekka Heumueller
Role: PRINCIPAL_INVESTIGATOR
University Hospital Aachen, Hospital Pharmacy, Steinbergweg 20, 52074 Aachen, Germany
Nicolaus Marx, Prof. Dr. med.
Role: PRINCIPAL_INVESTIGATOR
University Hospital Aachen,Internal Medicine I (Cardiology, Pneumology, Angiology and Internal Intensive Medicine)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Aachen
Aachen, , Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lenssen R, Schmitz K, Griesel C, Heidenreich A, Schulz JB, Trautwein C, Marx N, Fitzner C, Jaehde U, Eisert A. Comprehensive pharmaceutical care to prevent drug-related readmissions of dependent-living elderly patients: a randomized controlled trial. BMC Geriatr. 2018 Jun 4;18(1):135. doi: 10.1186/s12877-018-0814-3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11-192
Identifier Type: -
Identifier Source: org_study_id